📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies. (2018)

First Author: Tran KT

Attributed to: UK Biobank (core renewal) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/apt.14796

PubMed Identifier: 29741272

Publication URI: http://europepmc.org/abstract/MED/29741272

Type: Journal Article/Review

Volume: 48

Parent Publication: Alimentary pharmacology & therapeutics

Issue: 1

ISSN: 0269-2813